QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Lymphopenia association with accelerated hyperfractionation and its effects on limited-stage small cell lung cancer patients' clinical outcomes 期刊论文 ANNALS OF TRANSLATIONAL MEDICINE, 2019, 卷号: 7, 期号: 16 作者:  Wang, Xin;  Lu, Jie;  Teng, Feifei;  Yu, Jinming 收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05 Limited-stage small cell lung cancer (LS-SCLC)  radiotherapy (RT)  chemoradiation therapy (CRT)  accelerated hyperfractionation  lymphopenia  absolute lymphocyte count (ALC)   Randomized phase III trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small-cell lung cancer 期刊论文 BMC CANCER, 2016, 卷号: 16 作者:  Sun, Yan;  Cheng, Ying;  Hao, Xuezhi;  Wang, Jie;  Hu, Chengping 收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05 Amrubicin  Cisplatin  Etoposide  ED-SCLC  Randomized clinical trial  Chinese   Randomized phase III trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small-cell lung cancer 期刊论文 BMC Cancer, 2016, 卷号: 16, 期号: 1, 页码: 265 作者:  Sun, Yan*;  Cheng, Ying;  Hao, Xuezhi;  Wang, Jie;  Hu, Chengping 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/03 Amrubicin  Chinese  Cisplatin  ED-SCLC  Etoposide  Randomized clinical trial   Randomized phase III trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small-cell lung cancer 期刊论文 2016, 卷号: 16, 页码: 265 作者:  Sun, Yan;  Cheng, Ying;  Hao, Xuezhi;  Wang, Jie;  Hu, Chengping 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/04 Amrubicin  Cisplatin  Etoposide  ED-SCLC  Randomized clinical trial  Chinese